Researchers evaluated responses from monthly surveys distributed between June 2020 and January 2021. Of 82,319 respondents, 3,904 reported a prior COVID-19 infection. Findings showed more than half of COVID-19 survivors met the criteria for moderate or severe depression.
Those who reported having a headache while they had COVID-19 had an increased risk of depression symptoms, the analysis found. However, the study authors wrote they could not “exclude the possibility that individuals with current depression are more likely to recall or report headache.”
Overall, depression symptoms were more common among younger respondents compared to older respondents and men compared to women, according to the findings. The risk also increased with the level of self-reported COVID-19 illness severity.
“Our results add to a growing body of evidence suggesting the importance of considering potential neuropsychiatric sequelae of COVID-19 infection,” the study said. “Our results also suggest the importance of considering strategies that might mitigate the elevated risk of depressive symptoms following acute infection.”
To view the full report, click here.
More articles on public health:
Survivor of 2014 Ebola epidemic likely source of new outbreak in West Africa, researchers say
US records minimal flu activity 6th week in a row — 5 CDC FluView takeaways
UK variant in all 50 states: 12 CDC findings to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
